FDA Drug Recalls

Recalls / Class III

Class IIID-1129-2018

Product

Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: Mayne Pharma, Greenville, NC 27834, NDC 68308-841-01.

Affected lot / code info
Lot: FG01517, Exp. 12/31/2019

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.

Recalling firm

Firm
Mayne Pharma Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1240 Sugg Pkwy, N/A, Greenville, North Carolina 27834-9006

Distribution

Quantity
6456 bottles
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2018-08-21
FDA classified
2018-08-28
Posted by FDA
2018-09-05
Terminated
2020-05-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1129-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls